Cancer Genetics, Inc. might be a bargain after year of price correction
/Why The Stock Market Is So Smitten With Cancer Genetics, Inc. (CGIX)?
Cancer Genetics, Inc. (NASDAQ:CGIX) stock enjoyed an overall uptrend of 11.94% from the beginning of 2019. The closing share price quoted for March 05, 2019 was $0.27. The 1.08% rally might have been tempting for an investor to buy at this point.
